ATE292461T1 - Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen - Google Patents

Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen

Info

Publication number
ATE292461T1
ATE292461T1 AT01958434T AT01958434T ATE292461T1 AT E292461 T1 ATE292461 T1 AT E292461T1 AT 01958434 T AT01958434 T AT 01958434T AT 01958434 T AT01958434 T AT 01958434T AT E292461 T1 ATE292461 T1 AT E292461T1
Authority
AT
Austria
Prior art keywords
ibuprofen
capsule
preparations
agent
filling
Prior art date
Application number
AT01958434T
Other languages
English (en)
Inventor
Soichiro Kato
Katsuyuki Tsumori
Yasuo Shinoda
Toshio Inagi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE292461T1 publication Critical patent/ATE292461T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01958434T 2000-08-25 2001-08-23 Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen ATE292461T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000255827 2000-08-25
PCT/JP2001/007223 WO2002015900A1 (fr) 2000-08-25 2001-08-23 Solutions d'ibuprofene destinees a etre mises en gelules et preparations en gelules

Publications (1)

Publication Number Publication Date
ATE292461T1 true ATE292461T1 (de) 2005-04-15

Family

ID=18744550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958434T ATE292461T1 (de) 2000-08-25 2001-08-23 Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen

Country Status (14)

Country Link
US (1) US20030187070A1 (de)
EP (1) EP1321140B1 (de)
JP (1) JP3553562B2 (de)
KR (1) KR100762115B1 (de)
CN (1) CN1215837C (de)
AT (1) ATE292461T1 (de)
AU (1) AU2001280124A1 (de)
CA (1) CA2419147C (de)
DE (1) DE60109945T2 (de)
EA (1) EA005494B1 (de)
ES (1) ES2240492T3 (de)
PT (1) PT1321140E (de)
TW (1) TWI285115B (de)
WO (1) WO2002015900A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0506764A (pt) * 2004-01-09 2007-05-22 Wyeth Corp microemulsões para composições farmacêuticas
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CA2796072A1 (en) 2010-04-15 2011-10-20 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
MX355775B (es) 2011-10-20 2018-04-30 Chromocell Corp Compuestos, composiciones y metodos para reducir o eliminar el sabor amargo.
WO2016001643A1 (en) * 2014-06-30 2016-01-07 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
WO2016084099A1 (en) * 2014-11-25 2016-06-02 Biological E Limited Soft gelatin capsule composition of anti-tussive agents
EP3863603A1 (de) 2018-10-08 2021-08-18 Chanelle Pharmaceuticals Manufacturing Ltd. Weichgelkapselformulierung, verfahren zu ihrer herstellung und ihre verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
RO118371B1 (ro) * 1991-05-13 2003-05-30 Boots Co Plc Compozitie farmaceutica continand sare de sodiu a s (-)ibuprofen
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
EP0695175A1 (de) * 1993-04-30 1996-02-07 The Procter & Gamble Company Überzogene pharmazeutische zusammensetzungen
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JPH08333246A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
ZA976189B (en) * 1996-07-12 1999-01-11 Novartis Consumer Health Sa Oral pharmaceutical combinations
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
EP1212091B1 (de) * 1999-09-11 2007-02-28 The Procter & Gamble Company Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger

Also Published As

Publication number Publication date
PT1321140E (pt) 2005-06-30
TWI285115B (en) 2007-08-11
KR100762115B1 (ko) 2007-10-04
EA200300292A1 (ru) 2003-10-30
CN1471389A (zh) 2004-01-28
EP1321140A4 (de) 2004-01-21
CN1215837C (zh) 2005-08-24
US20030187070A1 (en) 2003-10-02
KR20030068535A (ko) 2003-08-21
EA005494B1 (ru) 2005-02-24
EP1321140B1 (de) 2005-04-06
DE60109945T2 (de) 2006-04-27
WO2002015900A1 (fr) 2002-02-28
DE60109945D1 (de) 2005-05-12
AU2001280124A1 (en) 2002-03-04
ES2240492T3 (es) 2005-10-16
CA2419147A1 (en) 2003-02-10
JP3553562B2 (ja) 2004-08-11
CA2419147C (en) 2008-10-07
EP1321140A1 (de) 2003-06-25
JPWO2002015900A1 (ja) 2004-06-10

Similar Documents

Publication Publication Date Title
DE60109945D1 (de) IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN
Brandt The role of analgesics in the management of osteoarthritis pain
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
DE69421918T2 (de) Hochdosierte arzneizusammensetzungen
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
UA82979C2 (ru) Фармацевтическая композиция, пригодная для перорального введения, которая содержит no-высвобождающие нспвл, лекарственная форма, фармацевтическая комбинация и способы лечения
DE69928815D1 (de) Dosierungsform mit flüssiger formulierung
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
DE69719189T2 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
AR027554A1 (es) Nuevo sistema de adminstracion de farmacos autoemulsionante
DK1170003T3 (da) Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler
WO1995004528A3 (en) PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
IT1307852B1 (it) Un dispositivo per la somministrazione per via transcutanea dimolecole contenute in un prodotto veicolante relativamente viscoso,
AR036304A1 (es) Sistema nuevo de liberacion de droga autoemulsionable
HN2003000115A (es) Formulacion farmaceutica que comprende melatonina
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
AR034436A1 (es) Agentes terapeuticos.
IS6532A (is) Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag
ES2051658T3 (es) Comprimidos efervescentes faciles de administrar.
DE69729729D1 (de) Arzneimittel zur anwendung im mund
JPS5762220A (en) Embrocation for external use
Maru et al. Formulation and evaluation of tenoxicam gels for tropical use
AR027555A1 (es) Nuevo sistema de administracion de farmacos emulsionante

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties